Recruiting Spinal Muscular Atrophy Studies in Innsbruck
About Spinal Muscular Atrophy Clinical Trials in Innsbruck
Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder that causes loss of motor neurons, leading to progressive muscle weakness and atrophy. It is the leading genetic cause of infant death. Revolutionary gene therapies and SMN-enhancing drugs have transformed treatment.
There are currently 1 spinal muscular atrophy clinical trials recruiting participants in Innsbruck, . These studies are seeking a combined 200 participants. Research is being sponsored by Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Spinal Muscular Atrophy Clinical Trials in Innsbruck — FAQ
Are there spinal muscular atrophy clinical trials in Innsbruck?
Yes, there are 1 spinal muscular atrophy clinical trials currently recruiting in Innsbruck, . Browse the studies on this page to find one that fits.
How do I join a clinical trial in Innsbruck?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Innsbruck research site will contact you about next steps.
Are clinical trials in Innsbruck free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Innsbruck studies also compensate for your time and travel.
What spinal muscular atrophy treatments are being tested?
The 1 active trials in Innsbruck are testing new therapies including novel drugs, biologics, and treatment approaches for spinal muscular atrophy.
Data updated March 2, 2026 from ClinicalTrials.gov